Détail du document
Identifiant

doi:10.1186/s42238-023-00209-5...

Auteur
Banach, Diana Ferrero, Paola
Langue
en
Editeur

BioMed Central

Catégorie

Medicine & Public Health

Année

2023

Date de référencement

06/12/2023

Mots clés
cannabis endocannabinoid system cats dogs veterinary medicine cats dogs cannabis
Métrique

Résumé

Background In animals, the endocannabinoid system regulates multiple physiological functions.

Like humans, animals respond to preparations containing phytocannabinoids for treating several conditions.

In Argentina, laws 27350 and 27669 have expanded the possibility of studying beneficial and adverse effects.

Materials and methods We conducted a web-based survey of Argentinian Cannabis Veterinarians to make a situational diagnosis on the number of veterinary medicine professionals currently developing treatments with cannabinoids focusing on dogs and cats.

Results Among the species treated, 77% corresponded to dogs, while 21% were cats.

Pain, seizures, and behavior disorders are the most prevalent conditions in dogs.

Seven conditions and combinations were treated in cats.

Full-spectrum cannabis extract derived from three different chemotypes was administered alone or with standard medication.

Response to cannabis treatment was characterized based on improvement categorized according to clinical assessment.

Both dogs and cats showed different improvement grades in clinical signs.

Conclusion This analysis provides promising results regarding the medicinal use of cannabis in dogs and cats.

Based on this analysis, we propose to expand the training of professionals, obtain quality preparations, and initiate controlled trials to reinforce knowledge of the use of cannabinoids in veterinary medicine.

Banach, Diana,Ferrero, Paola, 2023, Cannabis and pathologies in dogs and cats: first survey of phytocannabinoid use in veterinary medicine in Argentina, BioMed Central

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced